This brochure contains information on Cure-TB, a referral program for tuberculosis patients and their contacts moving between the US and Mexico.
Favorite
2004
This report is from a consultation of experts held jointly by the World Health Organization (WHO) and Rockefeller Foundation. The report makes recommendations to the Stop TB Partnership (the Partnership) for confronting the health care workforce crisis in tuberculosis (TB) control. This is identified through three key areas for action: (1) building the evidence base for planning and advocacy, (2) positioning and advocacy, and (3) capacity building.
Favorite
Managers and Supervisors
Policy Makers
2004
This book is a guide for multi-center trials in high-burden countries.
Favorite
2004
Faced with four overlapping epidemics -- drug use, sexually transmitted infections, HIV/AIDS, and tuberculosis -- Central Asia may face a serious crisis in 20 years' time unless concerted action is taken now. This study, geared to policymakers, provides an epidemiological update and looks at actions taken already by governments, NGOs, and donors in four Central Asian countries...
Favorite
Policy Makers
2004
The "10/90 Gap" is the idea that only 10% of global health research is devoted to conditions accounting for 90% of the global disease burden.
This report dispels the myth of the 10/90 Gap in health research including research regarding tuberculosis. It calls for a more constructive approach to improving access to medicines for the poor.
Favorite
International Agencies
2004
This slide set depicts how TB is spread and how to differentiate between latent TB infection and active TB disease. It also lists symptoms of TB and discusses testing and treatment.
Favorite
2004
This film's primary focus is on DOTS in Rajasthan, India and on TB/HIV in Malawi, with scientific commentary provided by Dr. Douglas Young, chairman of the Stop TB Working Group on New Vaccines. A sub-theme running throughout the film is the urgent need for new tools -- drugs, diagnostics and vaccines -- in order to turn the tide against the epidemic.
Favorite
2004
This brochure provides information for people who may have been infected with the TB germ.
Favorite
2004
This resource is designed for use in the evaluation of tuberculosis (TB) contact investigations in congregate settings. It provides explanatory text and tools for assessing health care worker performance and skills as well as programmatic outcomes of contact investigations in congregate settings.
Favorite
Managers and Supervisors
2004
This video summarizes the key elements of the multi-faceted, private-public partnership that has been assembled by Lilly to meet the challenge of MDR-TB.
Several world-recognized experts from academia, international agencies, and from within the company talk about the challenges that developing nations face in implementing sound containment programs given the lack of awareness, adequately trained personnel and access to affordable drugs.
Favorite
Managers and Supervisors
2004
This manual provides practical guidance relating to the proper use of ambulatory infusion therapy for the treatment of MDR-TB. The guide offers a rationale for providing outpatient infusion therapy for MDR-TB in a clinic setting and describes how to organize the clinic to provide the therapy. In addition, it contains a wall chart which summarizes the daily tasks for providing infusion therapy.
Favorite
Managers and Supervisors
2004
This is a briefing document for policymakers, TB program staff, and health communicators on contemporary communication opportunities and challenges.
Favorite
Health Educators/Communicators
Managers and Supervisors
Policy Makers
2005
This publication describes Lights of Hope, a stand-alone National Tuberculosis Communication Strategy for use in Kenya in the fight against tuberculosis (TB). It is based on a study of health-seeking behaviours among Kenyans, strategy design workshops with stakeholders, and meetings with frontline TB workers...
Favorite
Community Leaders
International Agencies
Policy Makers
2005
These tools are primarily for urban TB programs wishing to improve secondary prevention of TB in those groups at high risk of progression to TB disease, including the homeless, chemically dependent, and mentally ill. The materials include sample letters, forms, and job descriptions and protocols as well as templates of these tools for adaptation to local programs...
Favorite
Outreach Workers
2005
This training manual is expected to help trainers in conducting the practical training of Acid Fast Bacilli (AFB) microscopy. For this purpose, only the essential components of microscopy practice are described in the order of the training process and in the simplest and most practical manner. Also, this material will help trainers and trainees to identify problems or weaknesses in their practice and determine ways to overcome them.
Favorite
International Agencies
Lab Personnel
2005
This World TB Day fact sheet provides information on the progress towards targets for case detection and cure in global TB control and in implementing the DOTS strategy.
Favorite
International Agencies
Policy Makers
2005
This website raises worldwide awareness about the international health threat posed by tuberculosis. For World TB Day 2005, the Stop TB Partnership Secretariat proposes to focus on the central role of frontline TB care providers in the fight against TB. It includes three Briefing Notes that the Stop TB Partnership Secretariat will distribute for planning and implementing advocacy and social mobilization activities for World TB Day 2005.
Favorite
2005
This brochure provides general information on exposure to TB and lists the difference between TB infection and TB disease. It describes what a diagnostic test is, and what its results mean.
Favorite
2005
This brochure lists the difference between latent TB infection (LTBI) and active TB disease, and how to prevent active TB disease. It also provides drug information for treating LTBI and side effects that may occur from these medications.
Favorite
Persons With LTBI
2005
This brochure lists the symptoms of active tuberculosis (TB) disease and includes directions for curing TB. It also provides drug information for treating TB and side effects that may occur from these medications.
Favorite
2005